IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, K.
Right arrow Articles by Campochiaro, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, K.
Right arrow Articles by Campochiaro, P. A.
(Investigative Ophthalmology and Visual Science. 2002;43:1610-1615.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Intraocular Adenoviral Vector-Mediated Gene Transfer in Proliferative Retinopathies

Keisuke Mori1, Peter Gehlbach1, Akira Ando1, Karl Wahlin1, Vicky Gunther2, Duncan McVey2, Lisa Wei2 and Peter A. Campochiaro1

1 From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and 2 GenVec Inc., Gaithersburg, Maryland.

PURPOSE. The purpose of this study was to compare levels and patterns of expression of reporter genes achieved with an E1-deleted and partially E3-deleted type 5 adenoviral (Ad) vector after intravitreous or subretinal injections, or after intravitreous injections in mouse eyes with proliferative retinopathies.

METHODS. Ad vectors containing reporter gene constructs were injected into the vitreous cavity or subretinal space of wild-type mice or mice with proliferative retinopathies, and quantitative comparisons were made of expression of transgenes.

RESULTS. In normal eyes, peak Ad-mediated expression of luciferase, driven by a cytomegalovirus (CMV) promoter, occurred after injection of 107 to 108 viral particles and was 10 times greater after subretinal injections than after intravitreous injections. Intravitreous injections of Ad containing ß-galactosidase (LacZ) expression constructs (AdLacZ.10) resulted in strong expression of LacZ in epithelial cells of the iris and ciliary body and focal expression in the retina. Subretinal injections of AdLacZ.10 resulted in strong expression in RPE cells. Expression of LacZ after intravitreous injection of AdLacZ.10 was significantly greater in mice with two types of proliferative retinopathy (ischemic retinopathy or transgenic mice with retina-specific expression of platelet-derived growth factor (PDGF)-BB or PDGF-AB) than littermate control animals. Cells within epiretinal membranes and activated Müller cells were preferentially transduced in eyes with proliferative retinopathy.

CONCLUSIONS. These data suggest that although higher intraocular expression levels can be achieved after subretinal injection of adenoviral vectors, intravitreous injections provide good transduction of cells lining the vitreous cavity. Compared with normal eyes, eyes with proliferative retinopathy showed increased transduction, which occurred preferentially in cells participating in the disease process. Intravitreous injection of adenoviral vectors containing appropriate expression constructs may provide a good strategy for acute treatment of proliferative retinopathies, such as diabetic retinopathy and proliferative vitreoretinopathy.




This article has been cited by other articles:


Home page
IOVSHome page
C. Y. Park, R. S. Chuck, M. Cano, M. Yew, V. Nguyen, J. Parker, K. Mori, and P. L. Gehlbach
Periocular Triamcinolone Enhances Intraocular Gene Expression after Delivery by Adenovirus
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. M. Hamilton, D. E. Brough, D. McVey, J. T. Bruder, C. R. King, and L. L. Wei
Repeated Administration of Adenovector in the Eye Results in Efficient Gene Delivery
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 299 - 305.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Anzai, S. Yoneya, P. L. Gehlbach, D. Imai, L. L. Wei, and K. Mori
Laser Photocoagulation and, to a Lesser Extent, Photodynamic Therapy Target and Enhance Adenovirus Vector-Mediated Gene Transfer in the Rat Retina
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3883 - 3891.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Watanabe, H. Takagi, K. Suzuma, I. Suzuma, H. Oh, H. Ohashi, S. Kemmochi, A. Uemura, T. Ojima, E. Suganami, et al.
Transcription Factor Ets-1 Mediates Ischemia- and Vascular Endothelial Growth Factor-Dependent Retinal Neovascularization
Am. J. Pathol., May 1, 2004; 164(5): 1827 - 1835.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Takita, S. Yoneya, P. L. Gehlbach, E. J. Duh, L. L. Wei, and K. Mori
Retinal Neuroprotection against Ischemic Injury Mediated by Intraocular Gene Transfer of Pigment Epithelium-Derived Factor
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4497 - 4504.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology